Wed, Aug 20, 2014, 9:50 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Analog Devices, Inc. Message Board

  • Organovo. put it on your radar.
    "the company changed its business model to making tissues for drug companies for medical research and therapeutic applications instead.

    "Generally, the drug business can benefit significantly from these 3D tissues ... There's plenty of evidence that their processes are basically broken. They are inefficient and highly suspect," Renard said. "There's a big problem and they are looking for a better solution."

    Organovo, which trades on the OTC market, wants to be that solution.

    The company has partnered with Pfizer and United Therapeutics, and while Renard would not disclose the details of their partnership, he did say that the companies have a business arrangement in which funding is provided and some rights are shared.

    Renard did not disclose any other drug companies that are partnering with Organovo.

    But Organovo, which has made blood vessels, lung tissue and recreated tumors using bio-printing, is customizing tissue of all types for its current partners' medical research, Renard said.

    "We build custom tissue for them," Renard said. "They may have specific cell lines, disease areas of interests and they want a proprietary model for them ... we can make it."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ADI
52.165+0.445(+0.86%)Aug 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.